CN107348490A - A kind of compound calcium - Google Patents
A kind of compound calcium Download PDFInfo
- Publication number
- CN107348490A CN107348490A CN201710725809.4A CN201710725809A CN107348490A CN 107348490 A CN107348490 A CN 107348490A CN 201710725809 A CN201710725809 A CN 201710725809A CN 107348490 A CN107348490 A CN 107348490A
- Authority
- CN
- China
- Prior art keywords
- parts
- oyster shell
- raw material
- compound calcium
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 24
- 239000011575 calcium Substances 0.000 title claims abstract description 24
- 150000001875 compounds Chemical class 0.000 title claims abstract description 19
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 10
- 240000000249 Morus alba Species 0.000 claims abstract description 10
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 10
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 10
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 10
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 10
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 10
- 235000020234 walnut Nutrition 0.000 claims abstract description 10
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 9
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 8
- 240000007049 Juglans regia Species 0.000 claims abstract 3
- 244000234609 Portulaca oleracea Species 0.000 claims abstract 3
- 239000000843 powder Substances 0.000 claims description 21
- 238000000227 grinding Methods 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000011159 matrix material Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 14
- 230000036541 health Effects 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 210000003734 kidney Anatomy 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000036772 blood pressure Effects 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 2
- 239000008103 glucose Substances 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 241000758789 Juglans Species 0.000 description 7
- 241000219304 Portulacaceae Species 0.000 description 7
- 241000361919 Metaphire sieboldi Species 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000012414 sterilization procedure Methods 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 240000006698 Spigelia anthelmia Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- -1 kidney tonifying Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 230000000803 paradoxical effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of compound calcium, field of health care products is related generally to.Its raw material includes by weight：40~50 parts of oyster shell, 35~45 parts of Cordyceps militaris, 5~10 parts of dragon protein, 3~5 parts of lotus seeds, 2~4 parts of mulberry leaf, 2~5 parts of purslane, 3~10 parts of walnut kernel.The beneficial effects of the present invention are：It can kidney tonifying, effective strengthen immunity, reduce blood glucose, blood fat and blood pressure, and without any toxicity and side effects, there is higher health value.
Description
Technical field
The present invention relates to field of health care products, specifically a kind of compound calcium.
Background technology
After more than 25 years old, with the growth at people's age, every function of its body is in downward trend.Meanwhile
Cumulative with live and work pressure, the health status of adult increasingly declines, the life of fast pace high intensity to people with
The problem of carrying out many health aspects.Wherein, it is the most universal with four calcium deficiency, deficiency of the kidney, three height, hypoimmunity problems, and often
Coexist, interact, seriously endanger the health of adult.
At the same time, as people deepen continuously to healthy understanding, and the continuous improvement of quality of the life, it is more and more
People focus on to health maintenance.Therefore various nutrition, the demand of health products rise year by year.However, the product on existing market, pin
The problem of calcium deficiency that people are frequently accompanied by, deficiency of the kidney, three high, hypoimmunity, curative effect be present and cover incomplete situation, i.e., without
Method have simultaneously replenish the calcium, kidney tonifying, three high drop, the effect of strengthen immunity, it is impossible to the health demand of effectively corresponding people.Meanwhile
Nutriment on existing market, more using drug ingedient, certain toxic side effect is caused to human body unavoidably, is unfavorable for body and is good for
Health.
The content of the invention
It is an object of the invention to provide a kind of compound calcium, kidney tonifying, effective strengthen immunity while it replenishes the calcium, blood is reduced
Sugar, blood fat and blood pressure, and without any toxicity and side effects, there is higher health value.
The present invention to achieve the above object, is achieved through the following technical solutions：
A kind of compound calcium, its raw material include by weight：40~50 parts of oyster shell, 35~45 parts of Cordyceps militaris, earthworm egg
White 5~10 parts, 3~5 parts of lotus seeds, 2~4 parts of mulberry leaf, 2~5 parts of purslane, 3~10 parts of walnut kernel.
Further, its raw material includes by weight：42 parts of oyster shell, 38 parts of Cordyceps militaris, 8 parts of dragon protein, lotus seeds 4
Part, 3 parts of mulberry leaf, 4 parts of purslane, 7 parts of walnut kernel.
Compound calcium is made by the following method：
1) each raw material is weighed by weight；
2) oyster shell attachment is removed, is baked to, crushes, after elutriation grinding, oyster shell powder is made；
3) other raw materials in addition to oyster shell are crushed, grinding, raw material powder is made；
4) oyster shell powder and raw material powder are mixed, and 30~60min of low temperature sterilization is carried out under the conditions of 68~72 DEG C, i.e.,
.
Further, it is 30min that the sterilising temp duration of the step 4) is optimal.
During concrete application, add acceptable carrier, matrix or auxiliary material in pharmacy and be mixed and made into oral formulations.And can
So that one kind in powder, tablet, granule, capsule, emulsion, supensoid agent is made, is finally dispensed or packed, produced into
Product.
Prior art is contrasted, the beneficial effects of the present invention are：
The present invention can preferably correspond to the health problem of modern a middle-aged person, the elderly, at the same have and replenish the calcium, kidney tonifying, drop
Blood glucose, reducing blood lipid, the effect of hypotensive and strengthen immunity, meet the health demand of people.Meanwhile the former material of this product
Material is wholefood composition, does not add medicine, without any side effects.Can be long-term use of, to body without any bad shadow
Ring.
Meanwhile by by tabletting of the present invention, the forms such as electuary, capsule are made, be convenient for carrying and take, adapt to people save soon
The demand played.
Embodiment
With reference to specific embodiment, the present invention is expanded on further.It should be understood that these embodiments are merely to illustrate the present invention
Rather than limitation the scope of the present invention.In addition, it is to be understood that after the content of the invention lectured has been read, people in the art
Member can make various changes or modifications to the present invention, and these equivalent form of values equally fall within scope defined herein.
A kind of compound calcium, its raw material include by weight：40~50 parts of oyster shell, 35~45 parts of Cordyceps militaris, earthworm egg
White 5~0 parts, 3~5 parts of lotus seeds, 2~4 parts of mulberry leaf, 2~5 parts of purslane, 3~10 parts of walnut kernel.
Wherein, natural oyster shell can have preferable effect of supplemented calcium.Purslane has clearing heat and detoxicating effect.Pupa worm
Grass and ground dragon protein, which all have, reconciles human immune system, the effect of strengthen immunity.There is decompression to drop for lotus seeds, mulberry leaf walnut kernel
The effect of cholesterol.
Compound calcium can be made by the following method：
1) each raw material is weighed by weight；
2) oyster shell attachment is removed, is baked to, crushes, after elutriation grinding, oyster shell powder is made；
3) other raw materials in addition to oyster shell are crushed, grinding, raw material powder is made, grinding preferably remains each component
Original trace element and action effect, are relatively beneficial to the absorption of human body；
4) oyster shell powder and raw material powder are mixed, and 30~60min of low temperature sterilization is carried out under the conditions of 68~72 DEG C, so
Extent of killing bacteria pathogenic microorganisms can be killed completely, ensure that edible safe and reliable of product, while farthest retain
Nutritive value.
Further, it is 30min that the sterilising temp duration of the step 4) is optimal.Can either effectively it sterilize, it is again as far as possible big
Reservation nutritive value.
During concrete application, add acceptable carrier, matrix or auxiliary material in pharmacy and be mixed and made into oral formulations.And can
So that one kind in powder, tablet, granule, capsule, emulsion, supensoid agent is made, is finally dispensed or packed, produced into
Product.
With reference to embodiment, the present invention is further illustrated.
Embodiment 1：A kind of compound calcium, is formulated and is：Oyster shell 40g, Cordyceps militaris 40g, earthworm protein 10 g, lotus seeds 3g, mulberry leaf
2g, purslane 2g, walnut kernel 3g.
Powder is made through removal attachment, drying, crushing, elutriation processing in oyster shell, remaining raw material is crushed, grinding is made
Into powder, by 68~72 DEG C of cold sterilization sterilization procedures after mixing, a bag 2g is packed as, is produced.
Embodiment 2：A kind of compound calcium, is formulated and is：Oyster shell 45g, Cordyceps militaris 35g, dragon protein 5g, lotus seeds 4g, mulberry leaf
3g, purslane 4g, walnut kernel 4g.
Powder is made through removal attachment, drying, crushing, elutriation processing in oyster shell, remaining raw material is crushed, grinding is made
Into powder, by 68~72 DEG C of cold sterilization sterilization procedures after mixing, then pack and produce.
Embodiment 3：A kind of compound calcium, is formulated and is：Oyster 42g, Cordyceps militaris 38g, dragon protein 8g, lotus seeds 4g, mulberry leaf 3g,
Purslane 4g, walnut kernel 7g.Powder is made through removal attachment, drying, crushing, elutriation processing in oyster shell, remaining raw material
Powder is made in crushing, grinding, by 68~72 DEG C of cold sterilization sterilization procedures after mixing, is packed as a bag 2g, produces.
Volunteer takes Verification Project, is taken with the compound calcium that above-described embodiment 3 is obtained, and dosage is one day one
Bag, orally directly takes, as a result as follows：
1) after the volunteer of 100 30-35 one full year of life of selection takes 6 months, then the contemporary with not taking this product contrasts, stream
Feel season illness rate only 5%, normal cohort's illness rate of uniting is 60%.Subsequently continue to take this product at ensuing 1 year
In Influenza flu season, flu the incidence of disease be kept between 5%-10%, the normal population incidence of disease well below 60%.
2) 100 the three high patients are chosen, after taking 6 months, in the case where other conditions are constant, blood pressure and blood lipoid and blood pressure
It is kept at and strives within the scope of production, there is relatively good food therapy effect.
3) male's soreness and weakness of waist and knees, the Patients with Kidney Deficiency Type of 40-50 one full year of life is chosen, after taking 6 months, soreness and weakness of waist and knees situation substantially changes
Kind, renal function significantly improves.
Conclusion：Paradoxical reaction is no different using body after this product, and advantages of good calcium supplying effect after invented food, immunity significantly improves, blood
Sugar, blood fat, blood pressure improve significantly, and renal function has obvious enhancing.
Claims (6)
- A kind of 1. compound calcium, it is characterised in that：Its raw material includes by weight：40~50 parts of oyster shell, Cordyceps militaris 35~45 Part, 5~10 parts of dragon protein, 3~5 parts of lotus seeds, 2~4 parts of mulberry leaf, 2~5 parts of purslane, 3~10 parts of walnut kernel.
- A kind of 2. compound calcium according to claim 1, it is characterised in that：Its raw material includes by weight：42 parts of oyster shell, 38 parts of Cordyceps militaris, 8 parts of dragon protein, 4 parts of lotus seeds, 3 parts of mulberry leaf, 4 parts of purslane, 7 parts of walnut kernel.
- A kind of 3. compound calcium according to claim 1 or claim 2, it is characterised in that：It is made by the following method：1) each raw material is weighed by weight；2) oyster shell attachment is removed, is baked to, crushes, after elutriation grinding, oyster shell powder is made；3) other raw materials in addition to oyster shell are crushed, grinding, raw material powder is made；4) oyster shell powder and raw material powder are mixed, and 30~60min of low temperature sterilization is carried out under the conditions of 68~72 DEG C, produced.
- A kind of 4. compound calcium according to claim 3, it is characterised in that：A length of 30min during the sterilising temp of the step 4).
- A kind of 5. compound calcium according to claim 1, it is characterised in that：During concrete application, adding can receive in pharmacy Carrier, matrix or auxiliary material be mixed and made into oral formulations.
- A kind of 6. compound calcium according to claim 1, it is characterised in that：During concrete application, be made powder, tablet, granule, One kind in capsule, emulsion, supensoid agent, and pack, get product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710725809.4A CN107348490A (en) | 2017-08-22 | 2017-08-22 | A kind of compound calcium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710725809.4A CN107348490A (en) | 2017-08-22 | 2017-08-22 | A kind of compound calcium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107348490A true CN107348490A (en) | 2017-11-17 |
Family
ID=60289884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710725809.4A Pending CN107348490A (en) | 2017-08-22 | 2017-08-22 | A kind of compound calcium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107348490A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108030911A (en) * | 2017-12-16 | 2018-05-15 | 陈延琼 | A kind of ground dragon protein composite sheet and preparation method thereof |
| CN110269226A (en) * | 2019-07-01 | 2019-09-24 | 佛山市欧若拉生物科技有限公司 | The formula of a kind of ground dragon protein calcium tablet |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1223118A (en) * | 1997-11-10 | 1999-07-21 | 李诚忠 | Process for producing biological active calcium |
| CN1559582A (en) * | 2004-03-05 | 2005-01-05 | 赵炳泰 | Natural calcium supplementing powder |
| CN101664191A (en) * | 2009-08-24 | 2010-03-10 | 江苏安惠生物科技有限公司 | Worm grass and glossy ganoderma polysaccharides calcium powder and production method thereof |
| CN104705475A (en) * | 2015-04-08 | 2015-06-17 | 王书敏 | Cordyceps sinensis calcium sheeted candies and preparation method thereof |
| CN104856063A (en) * | 2012-09-11 | 2015-08-26 | 李光博 | Health calcium |
-
2017
- 2017-08-22 CN CN201710725809.4A patent/CN107348490A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1223118A (en) * | 1997-11-10 | 1999-07-21 | 李诚忠 | Process for producing biological active calcium |
| CN1559582A (en) * | 2004-03-05 | 2005-01-05 | 赵炳泰 | Natural calcium supplementing powder |
| CN101664191A (en) * | 2009-08-24 | 2010-03-10 | 江苏安惠生物科技有限公司 | Worm grass and glossy ganoderma polysaccharides calcium powder and production method thereof |
| CN104856063A (en) * | 2012-09-11 | 2015-08-26 | 李光博 | Health calcium |
| CN104705475A (en) * | 2015-04-08 | 2015-06-17 | 王书敏 | Cordyceps sinensis calcium sheeted candies and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108030911A (en) * | 2017-12-16 | 2018-05-15 | 陈延琼 | A kind of ground dragon protein composite sheet and preparation method thereof |
| CN110269226A (en) * | 2019-07-01 | 2019-09-24 | 佛山市欧若拉生物科技有限公司 | The formula of a kind of ground dragon protein calcium tablet |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101574499A (en) | Capsule for calming heart and tranquilizing mind | |
| CN107581255A (en) | A kind of composition for improving sleep quality and preparation method thereof | |
| CN107348490A (en) | A kind of compound calcium | |
| CN104208425B (en) | A kind of Chinese medicine preparation for being used to nurse one's health critical hypertension | |
| CN105663204A (en) | Composition and preparation capable of improving immune function, resisting fatigue and treating cold as well as preparation method and application of composition | |
| CN103908592A (en) | Traditional Chinese medicine for detoxification and preparation method of traditional Chinese medicine | |
| CN103445216B (en) | Dried bird egg with effects of nourishing blood and calming nerves and preparation process thereof | |
| CN1315418C (en) | Instant drinking powder contg. black-fungus, oatmeal and spirulina, and its prepn. method | |
| CN109453317A (en) | A kind of anaesthetic and its preparation process for strengthening by means of tonics | |
| KR20110041141A (en) | Preparation and Processing of Functional Artificial Honey Added with Various Nutrients | |
| CN103330259A (en) | Food composition with functions of nourishing yin, moisturizing lung and clearing way heat and preparation method thereof | |
| CN107897621A (en) | A kind of abalone effervescent tablet production method | |
| CN105639618A (en) | Health food for enhancing immunity and preparation method thereof | |
| CN106071518A (en) | Blue or green juice beverage of wheat and preparation method thereof | |
| CN105494745A (en) | Health tea with efficacy of reducing blood pressure and preparation method of health tea | |
| CN103815348A (en) | Dahurian rose fruit yin-nourishing and dryness-moistening hot-pot condiment | |
| CN102961619A (en) | Traditional Chinese medicine composition for helping children to sleep and preparation method thereof | |
| CN106665776A (en) | Traditional Chinese medicine pastries for conditioning yin deficiency constitutions | |
| CN108450591A (en) | Male health care tea and preparation method thereof | |
| JP2011036190A (en) | Method for producing granular oral food and granular oral food produced by the method | |
| CN107960469A (en) | A kind of pearl milk powder for improving sleep and preparation method thereof | |
| CN105558216A (en) | Brain-invigorating healthcare hazel chocolate sauce and preparation technology thereof | |
| CN108967980A (en) | A kind of food granules of prevention and treatment toxoplasmosis | |
| JPS5962526A (en) | Inorganic tonic medicine for improving human constitution | |
| CN106722866A (en) | A kind of children health-care nutrient powder and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171117 |
|
| RJ01 | Rejection of invention patent application after publication |